Search - tctmd.com

Displaying 321 - 340 of 862

Sort: Relevancy | Date

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Todd Neale

March 01, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Conference News STS 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

Todd Neale

February 03, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News AHA 2021

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

Todd Neale

November 18, 2021

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Presenter: Roberto Galea

November 06, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Advertisement

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

Modified Surgical MV Repair Stands Up to Replacement

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

February 2022 News Roundup

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

TCTMD’s Top 10 Most Popular Stories for November 2021

Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content